Beijing Luzhu Biotechnology Co (HKSE:02480) Dividends per Share : HK$0.00 (TTM As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Beijing Luzhu Biotechnology Co Dividends per Share?

Beijing Luzhu Biotechnology Co's dividends per share for the six months ended in Jun. 2024 was HK$0.00. Its dividends per share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.00. Its Dividend Payout Ratio for the six months ended in Jun. 2024 was 0.00. As of today, Beijing Luzhu Biotechnology Co's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Beijing Luzhu Biotechnology Co Dividends per Share Historical Data

The historical data trend for Beijing Luzhu Biotechnology Co's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Luzhu Biotechnology Co Dividends per Share Chart

Beijing Luzhu Biotechnology Co Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Dividends per Share

Beijing Luzhu Biotechnology Co Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Dividends per Share	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Beijing Luzhu Biotechnology Co's Dividends per Share

For the Biotechnology subindustry, Beijing Luzhu Biotechnology Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beijing Luzhu Biotechnology Co's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Luzhu Biotechnology Co's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Beijing Luzhu Biotechnology Co's Dividend Yield % falls into.

Save Embed

;

Save Embed

;

Beijing Luzhu Biotechnology Co Dividends per Share Calculation

Dividends paid to per common share.

Beijing Luzhu Biotechnology Co (HKSE:02480) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Beijing Luzhu Biotechnology Co's Dividend Payout Ratio for the quarter that ended in Jun. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jun. 2024 )	/	EPS without NRI (Q: Jun. 2024 )
	=	0	/	-0.609
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Beijing Luzhu Biotechnology Co Dividends per Share Related Terms

Thank you for viewing the detailed overview of Beijing Luzhu Biotechnology Co's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Luzhu Biotechnology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Luzhu Biotechnology Co Ltd (HKSE:02480) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3 Guangtong Street, Industrial Development Zone, Zhangjiawan Tongzhou District, Beijing, CHN

Website

http://www.luzhubiotech.com

Beijing Luzhu Biotechnology Co Ltd is a biotechnology company committed to developing human vaccines and therapeutic biologics to prevent and control infectious diseases and treat cancer and autoimmune diseases. Its clinical-stage product candidates comprise one vaccine candidate, LZ901 and two antibody injection product candidates, including K3 and K193. LZ901 is its Core Product.

Executives

Kong Jian	2101 Beneficial owner
Zhang Yanping	2202 Interest of your spouse
Ma Jianan	2201 Interest of corporation controlled by you
Zhu Hai Heng Qin Lv Zhu Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Bei Jing Lv Zhu Kang Rui Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Bei Jing Sai Sheng Yao Ye Gu Fen You Xian Gong Si	2101 Beneficial owner
Bei Jing Yi Zhuang Er Qi Sheng Wu Yi Yao Chan Ye Tou Zi Ji Jin You Xian He Huo	2101 Beneficial owner
Bei Jing Yi Zhuang Sheng Wu Yi Yao Bing Gou Tou Zi Zhong Xin You Xian He Huo	2101 Beneficial owner
Tian Jin Sai Ding Fang De Zi Chan Guan Li Zhong Xin	2201 Interest of corporation controlled by you
Tian Jin Sai De Rui Bo Zi Chan Guan Li Zhong Xin	2201 Interest of corporation controlled by you
Bei Jing Yi Tang Sai Ying Ji Jin Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
China Construction Bank Corporation	2201 Interest of corporation controlled by you
Central Huijin Investment Ltd.	2201 Interest of corporation controlled by you
Peng Ling	2201 Interest of corporation controlled by you
Ma Biao	2201 Interest of corporation controlled by you

Beijing Luzhu Biotechnology Co Headlines

No Headlines